Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: synthesis, QSAR study, and metabolic stability

Jarosław Sławiński , Krzysztof Szafrański , Aneta Pogorzelska , Beata Żołnowska , Anna Kawiak , Katarzyna Macur , Mariusz Belka , Tomasz Bączek


Author Jarosław Sławiński
Jarosław Sławiński,,
, Krzysztof Szafrański
Krzysztof Szafrański,,
, Aneta Pogorzelska
Aneta Pogorzelska,,
, Beata Żołnowska
Beata Żołnowska,,
, Anna Kawiak (IFB / IB / DBiotech) - [Medical Uniwersity of Gdańsk (GUMed)]
Anna Kawiak,,
- Department of Biotechnology
- Gdański Uniwersytet Medyczny
, Katarzyna Macur (IFB / ZLS)
Katarzyna Macur,,
- Zespół Laboratoriów Specjalistycznych MWB UG i GUMed
, Mariusz Belka
Mariusz Belka,,
, Tomasz Bączek
Tomasz Bączek,,
Journal seriesEuropean Journal of Medicinal Chemistry, ISSN 0223-5234, (A 40 pkt)
Issue year2017
Publication size in sheets0.6
Keywords in English2-mercaptobenzenesulfonamide, synthesis, 1,3,4-oxadiazole, anticancer activity, QSAR, metabolic stability
ASJC Classification1605 Organic Chemistry; 3002 Drug Discovery; 3004 Pharmacology; 2700 General Medicine
Languageen angielski
LicenseJournal (articles only); published final; Other open licence; after publication
Score (nominal)40
ScoreMinisterial score = 40.0, 24-07-2019, ArticleFromJournal
Publication indicators Scopus SNIP (Source Normalised Impact per Paper): 2016 = 1.562; WoS Impact Factor: 2017 = 4.816 (2) - 2017=4.527 (5)
Citation count*
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.